+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Topical Drug Delivery Market Research Report by Product, by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 4829843
  • Report
  • June 2020
  • Region: Global
  • 205 pages
  • 360iResearch™
until Dec 31st 2020
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now
The Global Topical Drug Delivery Market to Grow USD 126,194.15 Million by 2025, at a CAGR of 5.81%


  • Absorption Systems LLC
  • Bayer AG
  • Cipla Limited
  • GlaxoSmithKline plc
  • MedPharm Ltd.
  • Merck & Co., Inc.
  • MORE
The Global Topical Drug Delivery Market is expected to grow from USD 89,895.97 Million in 2019 to USD 126,194.15 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 5.81%.

Market Segmentation & Coverage:

This research report categorizes the Topical Drug Delivery to forecast the revenues and analyze the trends in each of the following sub-markets:

On the basis of Product, the Topical Drug Delivery Market is examined across Liquid Formulations, Semi-Solid Formulations, Solid Formulations, and Transdermal Products. The Liquid Formulations further studied across Solutions and Suspensions. The Semi-Solid Formulations further studied across Creams, Gels, Lotions, Ointments, and Pastes. The Solid Formulations further studied across Powders and Suppositories. The Transdermal Products further studied across Transdermal Patches and Transdermal Semi-Solids.

On the basis of Rout to Administration, the Topical Drug Delivery Market is examined across Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, and Vaginal Drug Delivery.

On the basis of End-User, the Topical Drug Delivery Market is examined across Burn Centers, Home Care Settings, and Hospitals and Clinics.

On the basis of Geography, the Topical Drug Delivery Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is examined across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is examined across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is examined across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Topical Drug Delivery Market including Absorption Systems LLC, Bausch Health Companies Inc, Bayer AG, Cipla Limited, Crescita Therapeutics Inc., GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co., Inc., Janssen Global Services, LLC, MedPharm Ltd., Merck & Co., Inc., Mylan N.V., Nestlé S.A., Novartis International AG, and The Lubrizol Corporation.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Topical Drug Delivery Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Topical Drug Delivery Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Topical Drug Delivery Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Topical Drug Delivery Market?
4. What is the competitive strategic window for opportunities in the Global Topical Drug Delivery Market?
5. What are the technology trends and regulatory frameworks in the Global Topical Drug Delivery Market?
6. What are the modes and strategic moves considered suitable for entering the Global Topical Drug Delivery Market?
Note: Product cover images may vary from those shown
2 of 3


  • Absorption Systems LLC
  • Bayer AG
  • Cipla Limited
  • GlaxoSmithKline plc
  • MedPharm Ltd.
  • Merck & Co., Inc.
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
2.3.1. Competitive Strategic Window

3. Executive Summary
3.1. Market Outlook
3.2. Product Outlook
3.3. Rout to Administration Outlook
3.4. End-User Outlook
3.5. Geography Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Topical Drug Delivery Market, By Geography

5. Market Dynamics
5.1. Introduction
5.1.1. Drivers High prevalence of skin diseases Rising prevalence of eye diseases High incidence of burn injuries Increasing prevalence of diabetes
5.1.2. Restraints Preference for alternative modes of drug delivery
5.1.3. Opportunities Delivery of biologics through the transdermal route Self-administration and home care
5.1.4. Challenges Technical barriers related to skin irritation and permeability Drug failures and product recalls

6. Market Insights
6.1. Porters Five Forces Analysis
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitutes
6.1.3. Bargaining Power of Customers
6.1.4. Bargaining Power of Suppliers
6.1.5. Industry Rivalry
6.2. Cumulative Impact of COVID-19
6.3. Client Customizations

7. Global Topical Drug Delivery Market, By Product
7.1. Introduction
7.2. Liquid Formulations
7.2.1. Solutions
7.2.2. Suspensions
7.3. Semi-Solid Formulations
7.3.1. Creams
7.3.2. Gels
7.3.3. Lotions
7.3.4. Ointments
7.3.5. Pastes
7.4. Solid Formulations
7.4.1. Powders
7.4.2. Suppositories
7.5. Transdermal Products
7.5.1. Transdermal Patches
7.5.2. Transdermal Semi-Solids

8. Global Topical Drug Delivery Market, By Rout to Administration
8.1. Introduction
8.2. Dermal Drug Delivery
8.3. Nasal Drug Delivery
8.4. Ophthalmic Drug Delivery
8.5. Rectal Drug Delivery
8.6. Vaginal Drug Delivery

9. Global Topical Drug Delivery Market, By End-User
9.1. Introduction
9.2. Burn Centers
9.3. Home Care Settings
9.4. Hospitals and Clinics

10. Americas Topical Drug Delivery Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Topical Drug Delivery Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand

12. Europe, Middle East & Africa Topical Drug Delivery Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding

14. Company Usability Profiles
14.1. Absorption Systems LLC
14.2. Bausch Health Companies Inc
14.3. Bayer AG
14.4. Cipla Limited
14.5. Crescita Therapeutics Inc.
14.6. GlaxoSmithKline plc
14.7. Glenmark Pharmaceuticals Limited
14.8. Hisamitsu Pharmaceutical Co., Inc.
14.9. Janssen Global Services, LLC
14.10. MedPharm Ltd.
14.11. Merck & Co., Inc.
14.12. Mylan N.V.
14.13. Nestlé S.A.
14.14. Novartis International AG
14.15. The Lubrizol Corporation

15. Appendix
15.1. Discussion Guide
15.2. Edition Details
15.3. License Details
15.4. Pricing Details
Note: Product cover images may vary from those shown
3 of 3
  • Absorption Systems LLC
  • Bausch Health Companies Inc
  • Bayer AG
  • Cipla Limited
  • Crescita Therapeutics Inc.
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals Limited
  • Hisamitsu Pharmaceutical Co., Inc.
  • Janssen Global Services, LLC
  • MedPharm Ltd.
  • Merck & Co., Inc.
  • Mylan N.V.
  • Nestlé S.A.
  • Novartis International AG
  • The Lubrizol Corporation
Note: Product cover images may vary from those shown